Cover image of the article: Alcoholic Cardiomyopathy: Clinical and Molecular Findings

Image Credit:Int Cardiovasc Res J

Alcoholic Cardiomyopathy: Clinical and Molecular Findings

Authors

M Correale1,*, I Laonigro2, F Altomare2, MDi Biase1
1Department of Cardiology, University of Foggia, Italy
2Institute of Internal Medicine, Department of Medical and Occupational Sciences University of Foggi, Italy
*Corresponding Author: Corresponding author: M Correale, Department of Cardiology, University of Foggia, Italy Email: opsfco@tin.it

International Cardiovascular Research Journal:Vol. 2, issue 1; e68544
Published online:Mar 31, 2008
Article type:Review Article
Received:Mar 14, 2018
Accepted:Mar 31, 2008
How to Cite:Correale M, Laonigro I, Altomare F, Biase M. Alcoholic Cardiomyopathy: Clinical and Molecular Findings. Int Cardiovasc Res J. 2009;2(1):e68544. doi:

Abstract

It has been known for some decades that chronic alcoholism can lead to dilated cardiomyopathy. Although excessive
drinking is known to result in alcoholic cardiomyopathy and light-to-moderate drinking may confer some
cardiovascular benefits, recent studies suggest that it is not only the quantity, but also drinking patterns and genetic
factors, that may influence the relation between alcohol consumption and cardiovascular disease. Alcoholic
patients consuming > 90g of alcohol a day for > 5 years are at risk for the development of asymptomatic alcoholic
cardiomyopathy. Those who continue to drink may become symptomatic and develop signs and symptoms of
heart failure. We summarize the experimental and clinical evidence regarding the role of alcohol in pathophysiology
of alcoholic cardiomyopathy.

Highlights

Fulltext

The full text is available in PDF.

References

  • 1.
    The references are available in PDF.

Copyright

© 2009, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

4
Jun
2022
The Relation Between Non-alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease

The Relation Between Non-alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease

Seyed Moayed Alavian,
Hosein Zadi

Alavian SM, Zadi H. The Relation Between Non-alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease. Multidiscip Cardio Annal. 2022;13(1):e121262. doi: https://doi.org/10.5812/mca-121262

1
Oct
2013
Androgenic Anabolic Steroid, Cocaine and Amphetamine Abuse and Adverse Cardiovascular Effects

Androgenic Anabolic Steroid, Cocaine and Amphetamine Abuse and Adverse Cardiovascular Effects

Efren Martinez-Quintana,
Beatriz Saiz-Udaeta,
Natalia Marrero-Negrin,
Xavier Lopez-Mérida,
Fayna Rodriguez-Gonzalez,
Vicente Nieto-Lago

Martinez-Quintana E, Saiz-Udaeta B, Marrero-Negrin N, Lopez-Mérida X, Rodriguez-Gonzalez F, et al. Androgenic Anabolic Steroid, Cocaine and Amphetamine Abuse and Adverse Cardiovascular Effects. Int J Endocrinol Metab. 2013;11(4):e8755. doi: https://doi.org/10.5812/ijem.8755

31
Dec
2025
Dilated Cardiomyopathy Presenting with Epigastric Pain, Mild Dyspnea and Rapidly Progressing Multi-Organ Failure

Dilated Cardiomyopathy Presenting with Epigastric Pain, Mild Dyspnea and Rapidly Progressing Multi-Organ Failure

Muneeba Malik,
Nauman Ismat Butt,
Aimen Zahra,
Tashia Malik,
Subhan Waseem,
Muhammad Tasawwar Amin

Malik M, Butt NI, Zahra A, Malik T, Waseem S, et al. Dilated Cardiomyopathy Presenting with Epigastric Pain, Mild Dyspnea and Rapidly Progressing Multi-Organ Failure. Multidiscip Cardio Annal. 2025;16(1):e165907. doi: https://doi.org/10.69107/mca-165907

30
Oct
2016
Cardiac failure secondary to hypocalcemia

Cardiac failure secondary to hypocalcemia

Mohammad Hasan Namazi,
Isa Khaheshi,
Mahsa Charkhkar,
Shooka Esmaeeli,
Habib Haybar

Namazi MH, Khaheshi I, Charkhkar M, Esmaeeli S, Haybar H. Cardiac failure secondary to hypocalcemia. Int J Cardiovasc Pract. 2016;1(3):e130044. doi: https://doi.org/10.21859/ijcp-010304

15
Jun
2020
Atrial Fibrillation as a Risk Marker in Patients with Decompensated Heart Failure

Atrial Fibrillation as a Risk Marker in Patients with Decompensated Heart Failure

Maryam Nabati,
Soheil Bakhshinasab,
Ali asghar Farsavian,
Fatemeh Rasolpor,
Jamshid Yazdani- Charati

Nabati M, Bakhshinasab S, Farsavian AA, Rasolpor F, Yazdani- Charati J. Atrial Fibrillation as a Risk Marker in Patients with Decompensated Heart Failure. Int Cardiovasc Res J. 2020;14(2):e103597. doi:

More by these authors

M CorrealePubMedScholar
I LaonigroPubMedScholar
F AltomarePubMedScholar
MDi BiasePubMedScholar
Share
Cited by
Metrics